Skip to main content

REVIEW article

Front. Oral. Health
Sec. Oral Cancers
Volume 5 - 2024 | doi: 10.3389/froh.2024.1461022
This article is part of the Research Topic Insights in Oral Cancers: 2023 View all 10 articles

Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward

Provisionally accepted
  • 1 Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Calabria, Italy
  • 2 Department of Clinical and Experimental Medicine, Magna Græcia University of Catanzaro, Catanzaro, Calabria, Italy

The final, formatted version of the article will be published soon.

    Oral squamous cell carcinoma (OSCC) is an aggressive disease whose incomplete biological comprehension contributes to the inappropriate clinical management and poor prognosis. Thus, the identification of new promising molecular targets to treat OSCC is of paramount importance. Ferroptosis is a regulated cell death caused by the iron-dependent accumulation of reactive oxygen species and the consequent oxidative damage of lipid membranes. Over the last five years, a growing number of studies has reported that OSCC is sensitive to ferroptosis induction and that ferroptosis inducers exert a remarkable antitumor effect in OSCC, even in those displaying low response to common approaches, such as chemotherapy and radiotherapy. In addition, as ferroptosis is considered an immunogenic cell death, it may modulate the immune response against OSCC. In this review, we summarize the so far identified ferroptosis regulatory mechanisms and prognostic models based on ferroptosis-related genes in OSCC. In addition, we discuss the perspective of inducing ferroptosis as a novel strategy to directly treat OSCC or, alternatively, to improve sensitivity to other approaches. Finally, we integrate data emerging from the research studies, reviewed here, through in silico analysis and we provide a novel personal perspective on the potential interconnection between ferroptosis and autophagy in OSCC.

    Keywords: oral squamous cell carcinoma, ferroptosis, Autophagy, prognosis, Signature, ferroptosis inducers

    Received: 07 Jul 2024; Accepted: 12 Aug 2024.

    Copyright: © 2024 Antonelli, Battaglia, Sacco, Petriaggi, Giorgio, Barone, Biamonte and Giudice. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Flavia Biamonte, Department of Clinical and Experimental Medicine, Magna Græcia University of Catanzaro, Catanzaro, 88100, Calabria, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.